Jeff Fairman

Immunology and Microbiology · Life Sciences

22h-index1.2kcitations62works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(10), Immune Response and Inflammation(9), Reproductive tract infections research(7), Viral gastroenteritis research and epidemiology(7), Influenza Virus Research Studies(6)

Publications62 total

A novel adjuvant system combining STING agonist-antigen conjugation with liposomal QS-21 exhibits potent synergistic Chlamydia vaccine immunogenicity
ImmPort·2026Open Access
A broad spectrum Shigella vaccine based on VirG53–353 multiepitope region produced in a cell-free system
npj Vaccines·2025· 1 citedOpen Access
Intranasal immunization with CPAF combined with ADU-S100 induces an effector CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum
UNC Libraries·2024Open Access
Intranasal immunization with CPAF combined with ADU-S100 induces an effector CD4 T cell response and reduces bacterial burden following intravaginal infection with Chlamydia muridarum
Vaccine·2024· 5 citedOpen Access
Intranasal immunization with CPAF combined with cyclic-di-AMP induces a memory CD4 T cell response and reduces bacterial burden following intravaginal infection with <i>Chlamydia muridarum</i>
2024Open Access
Structural Assessment of Chlamydia trachomatis Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds
Vaccines·2024· 5 citedOpen Access
A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older
Vaccine·2024· 9 citedOpen Access
Production of a covalent conjugate vaccine using cell-free protein expression (XpressCF™) and click chemistry
The Journal of Immunology·2024
Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate
npj Vaccines·2024· 12 citedOpen Access
Intranasal Immunization with Cpaf Combined with Cyclic-Di-Amp Induces a Memory Cd4 T Cell Response and Reduces Bacterial Burden Following Intravaginal Infection With Chlamydia Muridarum
SSRN Electronic Journal·2024· 1 citedOpen Access
Evaluating the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults aged 18 to 64 years: a phase 1/2, double-masked, dose-finding, active-controlled, randomised clinical trial
The Lancet Infectious Diseases·2023· 26 cited
The Group A Streptococcal Vaccine Candidate VAX-A1 Protects against Group B Streptococcus Infection via Cross-Reactive IgG Targeting Virulence Factor C5a Peptidase
Vaccines·2023· 7 citedOpen Access
A Novel <i>Shigella</i> O-Polysaccharide–IpaB Conjugate Vaccine Elicits Robust Antibody Responses and Confers Protection against Multiple <i>Shigella</i> Serotypes
mSphere·2023· 17 citedOpen Access
Addition of Lauryldimethylamine <i>N</i>-Oxide (LDAO) to a Copper-Free Click Chemistry Reaction Improves the Conjugation Efficiency of a Cell-Free Generated CRM197 Variant to Clinically Important <i>Streptococcus pneumoniae</i> Serotypes
ACS Omega·2022· 7 citedOpen Access
Non-Native Amino Acid Click Chemistry-Based Technology for Site-Specific Polysaccharide Conjugation to a Bacterial Protein Serving as Both Carrier and Vaccine Antigen
ACS Omega·2022· 22 citedOpen Access
Efficient production of immunologically active Shigella invasion plasmid antigens IpaB and IpaH using a cell-free expression system
Applied Microbiology and Biotechnology·2021· 15 citedOpen Access
SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
Nature Communications·2021· 100 citedOpen Access
1047. Development of a Next Generation 30+ Valent Pneumococcal Conjugate Vaccine (VAX-XP) Using Site-Specific Carrier Protein Conjugation
Open Forum Infectious Diseases·2021· 4 citedOpen Access
Repertoire of Naturally Acquired Maternal Antibodies Transferred to Infants for Protection Against Shigellosis
Frontiers in Immunology·2021· 20 citedOpen Access
A Porphyromonas gingivalis Capsule-Conjugate Vaccine Protects From Experimental Oral Bone Loss
Frontiers in Oral Health·2021· 11 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Neeraj Kapoor(17), Aym Berges(9), Leslie Bautista(7), James Rozzelle(6), L Nagarajan(6), Lucy Pill(6), Marcela F. Pasetti(6), Esther Ndungo(5), Liang Hong(4), David F. Claxton(4), Steven Dow(4), Paul Sauer(4), James Wassil(4), Girmay Desalegn(4), Lucy Pill-Pepe(4), Edwin V. Oaks(4), Aaron P. Esser‐Kahn(4), Lalitha Nagarajan(3), Taylor Rabara(3), Paresh Agarwal(3)